Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical data trend for Trulieve Cannabis's Buyback Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
STU:T0A vs ANIP, XERS, HROW: Buyback Yield % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Trulieve Cannabis's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Trulieve Cannabis Buyback Yield % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Trulieve Cannabis's Buyback Yield % distribution charts can be found below:
* The bar in red indicates where Trulieve Cannabis's Buyback Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Trulieve Cannabis (STU:T0A) has a Buyback Yield % of 0.00 as of Jul. 30, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Trulieve Cannabis and its competitors. According to the industry distribution chart, Trulieve Cannabis ranks #999999 out of 288 companies in the Drug Manufacturers industry.
Is Trulieve Cannabis' Buyback Yield % too high?
Trulieve Cannabis' current Buyback Yield % is 0.00. Based on the distribution chart, Trulieve Cannabis ranks #999999 out of 288 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Trulieve Cannabis has a GF Score™ of 63/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Trulieve Cannabis' Buyback Yield % compare to ANIP and XERS?
According to the Drug Manufacturers industry distribution chart, Trulieve Cannabis ranks #999999 out of 288 companies for Buyback Yield %. This places Trulieve Cannabis in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Drug Manufacturers company?
A good Buyback Yield % depends on the Drug Manufacturers industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Trulieve Cannabis and its competitors. Trulieve Cannabis's current Buyback Yield % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Trulieve Cannabis stock overvalued right now?
Based on GuruFocus' analysis, Trulieve Cannabis (STU:T0A) is currently considered Significantly Overvalued. The stock's GF Value™ is €5.15, compared to a current price of €6.93 — trading 34.6% above its estimated fair value. The current Buyback Yield % is 0.00. Trulieve Cannabis' overall GF Score™ is 63/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Trulieve Cannabis (STU:T0A), the current Buyback Yield % is 0.00 as of Jul. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Trulieve Cannabis (STU:T0A) Overvalued in 2026?
Based on GuruFocus' analysis, Trulieve Cannabis stock appears to be overvalued.
The current stock price of €6.93 is trading 34.6% above its estimated GF Value™ of €5.15.
GuruFocus considers Trulieve Cannabis to be Significantly Overvalued.
Key valuation signals for STU:T0A:
Buyback Yield %: 0.00
GF Value™: €5.15 vs. price of €6.93 (34.6% above fair value)
No single metric tells the full story. See the STU:T0A stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Trulieve Cannabis Corp is a vertically integrated cannabis company that grows, produces, and sells cannabis products. It has licenses to operate in Arizona, Colorado, Connecticut, Florida, Georgia, Maryland, Ohio, Pennsylvania, and West Virginia, where it sells medical cannabis products. In addition, the company sells cannabis products for adult use in Arizona, Colorado, Connecticut, Maryland, and Ohio. The firm's operations are substantially located in Florida and, to a lesser extent, in Arizona and Pennsylvania.
63GF Score
Get the complete analysis for STU:T0A
Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:T0A has been successfully added to your 
